Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Shijiazhuang Yiling Pharmaceutical Co.,Ltd.

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Beijing Yiling Bio-engineering Technology Co., Ltd.

    02 1Shijiazhuang Yiling Pharmaceutical Co., Ltd.

    03 2Yiling Pharmaceutical Ltd.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    PEGS Boston Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    PEGS Boston Summit
    Not Confirmed

    District Decision : Official Action Indicated

    Inspection End Date : 2024-10-11

    Shijiazhuang Yiling Pharmaceutical Co.,Ltd.

    City : Shijiazhuang

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Official Action Indicated

    Inspection End Date : 2024-10-11

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    PEGS Boston Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    PEGS Boston Summit
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2022-04-15

    Shijiazhuang Yiling Pharmaceutical Co.,Ltd.

    City : Miyun

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2022-04-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    PEGS Boston Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    PEGS Boston Summit
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-06-15

    Shijiazhuang Yiling Pharmaceutical Co.,Ltd.

    City : Shijiazhuang

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-06-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    PEGS Boston Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    PEGS Boston Summit
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-05-15

    Shijiazhuang Yiling Pharmaceutical Co.,Ltd.

    City : Miyun

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-05-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    PEGS Boston Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    PEGS Boston Summit
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-08-23

    Shijiazhuang Yiling Pharmaceutical Co.,Ltd.

    City : Shijiazhuang

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-08-23

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Shijiazhuang Yiling Pharmaceutical Co.,ltd. and get a quotation

    Shijiazhuang Yiling Pharmaceutical Co.,ltd. is a supplier offers 5 products (APIs, Excipients or Intermediates).

    Find Anastrozole bulk with DMF offered by Shijiazhuang Yiling Pharmaceutical Co.,ltd.

    Find Letrozole bulk with DMF offered by Shijiazhuang Yiling Pharmaceutical Co.,ltd.

    Find Memantine Hydrochloride bulk with DMF offered by Shijiazhuang Yiling Pharmaceutical Co.,ltd.

    Find 10-Deacetylbaccatin- III bulk offered by Shijiazhuang Yiling Pharmaceutical Co.,ltd.

    Find Paclitaxel bulk offered by Shijiazhuang Yiling Pharmaceutical Co.,ltd.

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.